期刊文献+

C-erbB2基因siRNA质粒的构建、鉴定及转染 被引量:4

Construction and identification of CerbB-2 siRNA expression plasmid and its transfer into human colon cancer cell lines HT-29
在线阅读 下载PDF
导出
摘要 目的构建人C-erbB2干扰载体pGenesil-erbB2,并稳定转染入CerbB-2高表达的人结肠癌细胞株HT-29细胞,观察其对人结肠癌HT-29细胞从转录后水平对Her-2蛋白表达的影响。方法利用免疫组化方法筛选出CerbB-2高表达细胞株HT-29,以人C-erbB2cDNA基因为靶标设计RNA干扰片段和阴性对照片段,退火形成双链并克隆进入载体pGenesil-erbB,进行鉴定及测序,并稳定转染至HT-29细胞。结果测序证明人C-erbB2siRNA表达载体质粒pGenesil-erbB构建成功,pGenesil-erbB稳定转染入人结肠癌HT-29细胞,采用Westernblot实验证明pGenesil-erbB可显著抑制Her-2蛋白的表达。结论成功构建了人CerbB2干扰载体质粒pGenesil-erbB,稳定转染至结肠癌HT-29细胞株,并能抑制HT-29细胞的Her-2蛋白的表达,为靶向CerbB2的siRNA对结肠癌的放射增敏研究奠定了基础。 Objective To construct a plasmid carrying small interfering RNA (siRNA) targeting human C-erbB2 gene (pGenesil- erbB2) and test its effect on Her-2 expression at the post-transcriptional level in human colon cancer cell lines HT-29 cells that highly express erbB2. Methods A HT-29 cell line that highly expressed CerbB-2 was selected using immunohistochemical method. The double-stranded siRNA targeting human CerbB-2 cDNA and the negative control fragment were cloned into pGenesil-1 vector, and after identification and sequence analysis, the constructed pGenesil-erbB2 plasmid was transfected into the selected HT-29 cell line. Results The pGenesil-erbB2 plasmid was successfully constructed and stably transferred into HT-29 cells. The transfection resulted in significant inhibition of Her-2 protein expression in the HT-29 cells, as shown by Western blotting. Conclusion The pGenesil-erbB plasmid we constructed can be stably transfected into HT-29 cells to inhibit the expression of Her-2 protein, and can be useful in further studies of increasing the radiosensitivity of HT-29 cell lines.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第9期1870-1873,共4页 Journal of Southern Medical University
关键词 载体构建 质粒 RNA干扰 CERBB2 SIRNA vector construction plasmid RNA interference CerbB2 small interfering RNA
  • 相关文献

参考文献13

  • 1Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans [J ]. Nature, 1998, 391:806-11.
  • 2Hammond SM, Caudy AA, Hannon GJ, et al. Post-transcriptional gene silencing by double-stranded RNA[J]. Nature Rev Gen, 2001, 2:110-9.
  • 3Lipardi C, Wei Q, Paterson BM, et al. RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs[J]. Cell, 2001, 107: 297-307.
  • 4Wall NR, Shi Y. Small RNA: can RNA interference be exploited for therapyEJ]. Lancet, 2003, 362: 1401-3.
  • 5Caplen NJ. Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference [J]. Gene Ther, 2004, 11: 1241-8.
  • 6Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA interference [J]. Nat Biotechnol, 2004, 22: 326.
  • 7Slamand J, Clark GM, Wang SG, et al. Human breast cancer: Correlation of relapse and survival with amplification of the HER22/neu oncogea[J].Seleace, 1987, 235(6): 177.
  • 8赵川,普苹,付红梅.c-erbB-2,nm23蛋白在结直肠癌组织中的表达及其意义[J].实用癌症杂志,2003,18(4):380-381. 被引量:6
  • 9牟兆新,侯振江.C-erbB2基因在恶性肿瘤中的研究进展[J].中国煤炭工业医学杂志,2006,9(1):4-6. 被引量:4
  • 10Tiseo M, Loprevite M, Ardizzoni A, et al. Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer[J].Curr Med Chem AntiCancer Agents, 2004, 4(2): 139-48.

二级参考文献25

  • 1汪良芝,沈云志,陈同钰,赵建妹,鲁常青.食管鳞癌中c-erbB-2和p53的表达及其临床意义[J].中华腹部疾病杂志,2003,3(3):161-163. 被引量:2
  • 2孟刚.c─erbB─2、ras p21及p53在大肠癌表达的免疫组化研究[J].临床与实验病理学杂志,1995,11(3):180-183. 被引量:16
  • 3全国大肠癌病理研究协作组.全国大肠癌病理研究统一规范[J].中华肿瘤杂志,1986,8:156-156.
  • 4Slaman DJ,Clark GM, Wong SG, et al. Human breast cancer:Correlation of relapse and survival with amplification of the HER-2/neu oncogen[J]. Science, 1987,235(6): 177.
  • 5Tsugawa K, Yonemura Y, Hirono Y, et al. Amplification of the c- met,c-erbB-2 and epidiermal growth factor receptor gene in human gastric cancer:correlation to clinical feat ures[J]. Oncology, 1998,55 (4) : 478.
  • 6Weiner DB, Nordberg J, Robinson R, et al. Expression of the neu gene-eneoded protein(P 185neu) in human nonsmall cell carcinoma of the lung[J]. Cancer Res, 1990,50(11) :421.
  • 7Chang K, Ding I, Kern FG, et al. Immunohistochemical analysis of p53 and Her-2/neu protein in human tumor[J] .J Histochem Cytochem, 1991,39(3) :1281.
  • 8Cohn KH, Wang F, Desoto-LaPais F, et al. Association of nm23-H,allelic delections with dislant metastases in colorectal carcinoma[J]. Lancet, 1991,338(6) : 722.
  • 9Ura H, Denno R, Hirata K. The significance of nm23 protein expression in human gastric carcinoma[J]. Surg Today, 1996,26(12) :957.
  • 10Tannapfel A, Kockerling F. Katalinic A, et al. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma [J]. Dis Colon Rectum, 1995, 38(6):651.

共引文献8

同被引文献35

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部